Picture of Apyx Medical logo

APYX Apyx Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Apyx Medical Corp reports results for the quarter ended in September - Earnings Summary

* Apyx Medical Corp  APYX.OQ  reported a quarterly adjusted loss
of 12 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 15 cents per share.
* Revenue rose 70.1% to $11.83 million from a year ago; 
analysts expected $10.20 million. 
* Apyx Medical Corp's reported EPS for the quarter was a loss
of 12 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Apyx Medical Corp shares had risen by 4.5% this quarter and
gained 101.1% so far this year.
* The company reported a quarterly loss of $4.22 million.
* Wall Street's median 12-month price target for Apyx Medical
Corp is $14.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 10:48 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Apyx Medical

See all news